Virtual 15th Int'l Pharma and Medical Device Ethics & Compliance Congress Announces Agenda-at-a-Glance; Early Bird Ends Friday
  • Virtual Online Video Event Live and Archived
  • Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
  • Media Partner: Policy & Medicine Compliance Update
  • May 17-20, 2022
Phone: 800-503-8171
Click here to register by March 25 for early bird discount.

Registration discounts now available with special ETHICS/EFPIA/FSA/IFPMA/MedTech Europe/PCF rates. Rates are up to 1,000 euros less than major competing events.
- Click Here -

-- click image to see larger version --

PARIS, FRANCE -- PHARMA UPDATE NEWS SERVICE™ -- MARCH 22, 2022: The Virtual Fifteenth International Pharmaceutical and Medical Device Ethics and Compliance Congress,, May 17 - 20, 2022, will take place in the form of online video broadcast which will be offered live and archived for 6 months following the live broadcast.


Pablo Rojas Abad, LLM
Senior Legal Counsel, MedTech Europe, Etterbeek, Belgium

Julie Bonhomme, Esq.
Legal & Compliance Director, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Robert I. Dodge, JD
Assistant Director, FCPA Unit, US Securities & Exchange Commission, Former Assistant Section, Environmental Defense Section, US Department of Justice, Washington, DC, USA

Derek J. Ettinger, JD, PhD
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC, USA

Theodoros Evgeniou, MEng, PhD
Professor, INSEAD; WEF Academic Partner, Artificial Intelligence, World Economic Forum, Fontainebleau, France

Antoinette Gawin, MSC
President & Chief Executive Officer, Terumo BCT; Chair, AdvaMed Board Ethics & Healthcare Compliance Committee, Denver, CO, USA

Anna-Elisabeth Krause-Ablass, JD
European Delegated Prosecutor, European Public Prosecutor's Office; Former Specialized Public Prosecutor for White Collar Crime Frankfurt, Frankfurt, Germany

Dominique Laymand, Esq.
Of Counsel, Clifford Chance; Former Executive Vice President, Ethics & Social Responsibility Officer, Ipsen; Honorary President, ETHICS, Paris, France

Oliver Medill
Managing Director, All About Impact; Author, The Impact Formula: Powerful Solutions for Turbo-charging your Influence, London, UK

Sofie Melis, MA
Director HR and Ethics & Compliance, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland

Piergiorgio Pepe, MA. EU Law
President, Quantum Ethics, Ethics and Compliance Lecturer, SciencesPo; Board Member ETHICS, Paris, France

David Shore
Faculty, Harvard University; Faculty, The Governance Institute; Advisory Board, McKinsey & Company; Professor of Innovation and Change, Tianjin University (China) & University of Monterrey, Business School (Mexico), Cambridge, MA, USA

Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Washington, DC, USA


Imelda Alvarez, LLB, MBA
Chief Executive Officer, Comply Latam, SC; Former Regional Integrity & Compliance Head, Latin America and Canada, Novartis, Mexico City, Mexico

Enno Behrendt, JD
Associate Director, Governance, Risk Management & Compliance, Guidehouse; Former Head of Compliance Diagnostic, Imaging and Services, Siemens Health, Nuremberg, Germany

Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Raleigh-Durham, NC, USA

Kathleen M. Boozang, JD, LLM
Dean and Professor of Law, Seton Hall University School of Law, Fellow, The Hastings Center, Newark, NJ, USA

Kirsten Bröckers, MBLT
Head Legal & Compliance EMEA, Novartis Gene Therapies; Former Head Legal & Compliance EMEA, AveXis; Former Head of Legal and Compliance, Vifor Fresenius Medical Care Renal Pharma, Basel, Switzerland

Maija Burtmanis, LLB/BSc LLM
General Counsel & Chief Compliance Officer, Zuellig Pharma; Regional Compliance Director, Japan/Asia Pacific, Shire, Singapore

Antonio Cavallaro
Compliance Officer & Supervisory Body, Merck Serono Italy, Rome, Italy

Stéphanie Chabin, Esq.
General Counsel, Global R&D, Ferring; Former VP Legal R&D, Ipsen, Copenhagen, Denmark

Ana Christian, JD
Assistant General Counsel, Global Functional Practice Group, Genentech, Los Angeles, CA, USA

Campbell Clark, LLB, MJ
Vice President, Legal & Compliance, APAC, Medtronic, Covidien Private Limited; Chair, Compliance Committee, APACMed, Singapore

Zachary N. Coseglia, JD
Managing Principal, Head of Innovation and Co-Lead. R&G Insights LAB, Ropes & Gray LLP; Former Assistant General Counsel, Pfizer, Boston, MA

Audrey DeGuarde, MSJ
Vice President Global Transparency, Porzio Life Sciences, New York, NY

Ario Dehghani, JD
Of Counsel and Head, Compliance and Investigation Practice Group, Baker & McKenzie, CIS, Limited, Kyiv, Ukraine

Peter Dieners, Esq.
Regional Managing Partner (Germany) and Head, Global Healthcare and Life Sciences Group, Clifford Chance, Dusseldorf, Germany

Gildas Durand
Partner/Principal, Ernst & Young LLP, Miami, FL, US

Sue Egan, MBA
Director, Sue Egan Associates; Board and Co-chair, Strategic Committee, ETHICS, Great Missenden, UK

Jacob Elberg, JD
Associate Professor, Seton Hall University School of Law; Former Assistant US Attorney, US Attorney's Office, District of New Jersey, Newark, NJ, USA

Steffen Esche
Director, Consulting, Risk & Regulatory, PwC, Frankfurt, Germany

George Fife
Partner, Forensic & Integrity Services, EY; Former Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Paris, France

Christopher J. Foreman, Esq.
Deputy Chief Privacy Officer, Merck Sharp & Dohme (Europe) Inc., Brussels, Belgium

Juan Luis Fuentes, Esq.
Ethics, Risk & Compliance, Head Latin America & Canada, Oncology, Novartis; Former Head of Legal and Compliance, Sandoz, East Hanover, NJ, USA

Elvira Valverde Garcia, LLM
Global Privacy Counsel, F.Hoffmann-La Roche Ltd; Former Corporate Counsel, Baxter International Inc., Zurich, Switzerland

Gary F. Giampetruzzi, JD
Partner, Paul Hastings; Former VP and Assistant General Counsel, Head of Investigations, Pfizer Inc. New York, NY, USA

Joe Henein
President and Chief Executive Officer, NewBridge Pharma; Former Regional Director, MEA, Wyeth, Dubai, UAE

Michael "Bret" Hood, MBA
CEO, 21st Century Learning & Consulting LLC; Former FBI Special Agent; Former Leadership Instructor, FBI's National Academy, Hillsborough, NC, USA

Bella Hovhannisyan, Esq.
Chief Ethics & Compliance Officer, CSL Behring AG; Member, ETHICS, Berne, Switzerland

Albert Hurtado
Global Customer Capabilities Manager, Amgen, Zurich, Switzerland

Els Janssens, LLM
Counsel, Baker & McKenzie, Brussels, Belgium

Vasiliki Kalaitzidis, JD
Vice President, Deputy General Counsel, Karyopharm Therapeutics Inc., Newton, MA, USA

Elisabeth Kohoutek, JD
Counsel, FDA and Life Sciences, King & Spalding, Frankfurt, Germany

Aline Lautenberg, Esq.
General Counsel and Director, Legal & Compliance, MedTech Europe, Brussels, Belgium

Cheryl Lee, MBA
Vice President, Global Market Compliance and Compliance Committees, Bristol-Myers Squibb; Former Vice President, Worldwide Markets, Healthcare Compliance, Celgene, Summit, NJ, USA

Gareth Lee, JD
Chief Compliance Officer & Asia Pacific General Counsel, Cordis; Former VP, Legal & Compliance, Asia Pacific, Cardinal Health, Singapore

Lei Li, LLM
Managing Partner, Beijing and Shanghai Offices, Sidley Austin; Former Third Secretary, Ministry of Commerce, People's Republic of China, Beijing, China

Michael K. Loucks, JD
Partner, Skadden Arps LLP; Former Acting US Attorney, District of Massachusetts, Washington, DC, USA

Desiree Maier, JD
Partner, Compliance and Investigations, Hogan Lovells; Lecturer, University of Augsburg, Munich, Germany

Inigo de la Maza, MSc, MBA
Data Scientist Solution Architect, F.Hoffmann-La Roche Ltd, Basel, Switzerland

Paul J. Melling, JD
Founding Partner, Baker & McKenzie, CIS, Limited, Moscow, Russia

Antje Meyer, LLM
Senior Manager, Forensic & Integrity Services, EY, Dusseldorf, Germany

Genevieve Michaux, LLM
Partner, FDA and Life Sciences, King & Spalding, Brussels, Belgium and Paris, France

Philippa Montgomerie, LLB
Vice President, Legal & Compliance, Medtronic, Edinburgh, Scotland, UK

Lena Moran-Adams, Esq.
Group Deputy General Counsel, Telix Pharma; Former Head of Legal and Business Conduct, Intercontinental Region, Gilead; Former Global Head of Legal, PLS, Novartis, Melbourne, Australia

Arthur Muratyan, Esq.
Secretary General, ETHICS; Former Chair, MedTech Compliance Panel, Paris, France

Jean-Claude Najar, JD, LLM
Compliance & ADR, Jean-Claude Najar Consultancy; Chair, MedTech Europe Compliance Panel, Paris, France

John Patrick Oroho, JD
Executive VP & Chief Strategy Officer, Porzio Life Sciences, LLC; Principal, Porzio Bromberg & Newman, PC, Morristown, NJ, USA

Rita Pan, MPH
Strategy Insights and Planning Associate Consultant, ZS, New York, NY, USA

Giota Papamarkou
Vice-President, Business Ethics North America & Global Monitoring, Ipsen; Former EMEA Compliance and Ethics Manager, BMS, Paris, France

Minal Patel, MS
Health Care Compliance Officer, Pharma and Consumer, Johnson & Johnson; Representative, Code Technical Advisory Committee, Johannesburg, South Africa

Oscar Perdomo
Director, Pharmaceutical & Life Sciences, Advisory Services, PwC Switzerland, Zurich, Switzerland

Nicole Peter
Global Compliance Leader, F.Hoffmann-La Roche Ltd, Zurich, Switzerland

Sergio Pinto, MBA
Sr. Director Compliance, Third Party Ethics & Compliance, Americas, Johnson & Johnson; Committee Member, Compliance Council Brasil, São Paulo, Brazil

Jenny Pu, CPA, CFE
Associate Director, Guidehouse Europe; Member, ETHICS, London, UK

Maria Eugenia (Maru) Quindimil, MBA
CEO and Founder, Socrates Compliance Consulting; Former Executive Director JAPAC, Amgen, Waianae, HI, USA

Maria Teresa Cantu Reus
Legal Advisor and Compliance Officer, FIFARMA; External Compliance Officer, AMIIF, Mexico City, Mexico

Michael L. Shaw, JD
Principal, Global Head of Risk & Compliance, ZS; Former VP & Compliance Officer, GSK, Philadelphia, PA, USA

Robert Stephenson
Director, PwC UK, London, UK

Geeta Thakerar, JD
Founder, Geeta Thakerar Consultancy Services; Former Chief Legal Counsel, Asia Pacific, Kimberly Clark, Singapore

Tamara Tubin, lic.iur.
Director, Ethics & Healthcare Compliance, Corporate, Johnson & Johnson; Board and Strategic Committee, ETHICS, Zurich, Switzerland

Elisabethann Wright, LLB
Partner, Cooley LLP, Brussels, Belgium

Mariusz Witalis
Partner, Forensic & Integrity Services, EY, Warsaw, Poland

Hady Zohdy
Ethics & Business Integrity Head for Egypt and Sudan, Sanofi; Chair, Egyptian Society For Pharmaceutical Researches (ESPR), Compliance Committee, Cairo, Egypt



Anne-Sophie Bricca
Deputy General Counsel & Senior Director Legal Affairs & Compliance, Terumo BCT; Chair, Ethics and Compliance Group and seats at the Code Committee, MedTech Europe; Brussels, Belgium

Stephen Nguyen Duc
Global Head of Ethics & Compliance and Executive Counsel, GE Healthcare Pharmaceutical Diagnostics; Board Member, Strategic Committee International Society of Healthcare Ethics and Compliance Professionals (ETHICS); Paris, France

Laura Nassar, PharmD
Vice President, Head of Ethics & Business Integrity, AEME Region, Sanofi; Former Head of Compliance Middle East, Roche Pharmaceuticals; Former Regional Pharma HCC Officer Emerging Markets, Johnson & Johnson; Beirut, Lebanon

Roeland Van Aelst
EMEA Lead, Third Party Intermediary, Ethics & Compliance, Johnson & Johnson; President, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS); Chairman, MedTech Europe Code Committee; Brussels, Belgium





Compliance Certification Board (CCB)®.
The International Congress is pending approval from the Compliance Certification Board (CCB)(r) to offer preapproved Live and Non-Live CCB CEUs.

Continuing Legal Education
The International Congress is pending approval to offer Pennsylvania CLE Credits.

Certificates of Attendance
Attendees may download and self-complete a certificate of attendance which will be posted on the Congress virtual video broadcast platform to file with appropriate certifying bodies which accept such.

The International Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying government representatives, consumer advocate organizations, academics, students, representatives of health services research organizations, and those who have lost their jobs as a result of the COVID-19 pandemic. Click here for more information.

  • Live and curated sessions streamed directly to you through our easy to navigate advanced virtual broadcast platform
  • New content, optimized for online learning, focused on new regulatory developments and managing ethics and compliance programs during the COVID 19 pandemic
  • Engage with faculty through polling, Q & A sessions, chat and direct video messaging
  • Network in real time with other attendees through direct attendee to attendee and group video messaging
  • Access to an extensive video archive of past Congress presentations providing a context for the evolution of the compliance professions and the legal and regulatory setting
  • Virtual exhibit hall featuring innovative solutions, products and services with opportunity to directly contact exhibitors for further information




Virtual Online Video Event Live and Archived
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partner: Policy & Medicine Compliance Update
May 17 - 20, 2022
Virtual Online Video Event Live and Archived
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Policy & Medicine Compliance Update
November 2022


For Congress registration information, visit, email, or call 800-503-8171.

For sponsorship and exhibit information, visit or contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or

For changes or additions, please email your request to:

For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.